Literature DB >> 29058403

Traced on the Timeline: Discovery of Acetylcholine and the Components of the Human Cholinergic System in a Primitive Unicellular Eukaryote Acanthamoeba spp.

Abdul Mannan Baig1, Zohaib Rana1, Sumayya Tariq1, Salima Lalani1, H R Ahmad1.   

Abstract

Acetylcholine (ACh) is the neurotransmitter of cholinergic signal transduction that affects the target cells via muscarinic (mAChR) and nicotinic (nAChR) cholinergic receptors embedded in the cell membrane. Of the cholinergic receptors that bind to ACh, the mAChRs execute several cognitive and metabolic functions in the human central nervous system (CNS). Very little is known about the origins and autocrine/paracrine roles of the ACh in primitive life forms. With the recent report of the evidence of an ACh binding mAChR1 like receptor in Acanthamoeba spp., it was tempting to investigate the origin and functional roles of cholinergic G-Protein coupled receptors (GPCRs) in the biology of eukaryotes. We inferred the presence of ACh, its synthetic, degradation system, and a signal transduction pathway in an approximately ∼2.0 billion year old primitive eukaryotic cell Acanthamoeba castellanii. Bioinformatics analysis, ligand binding prediction, and docking methods were used to establish the origins of enzymes involved in the synthesis and degradation of ACh. Notably, we provide evidence of the presence of ACh in A. castellanii by colorimetric analysis, which to date is the only report of its presence in this primitive unicellular eukaryote. We show the evidence for the presence of homology of evolutionary conserved key enzymes of the cholinergic system like choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) in A. castellanii spp., which were found to be near identical to their human counterparts. Tracing the origin, functions of ACh, and primeval mAChRs in primitive eukaryotic cells has the potential of uncovering covert cholinergic pathways that can be extended to humans in order to understand the states of cholinergic deficiency in neurodegenerative diseases (ND).

Entities:  

Keywords:  Acanthamoeba castellanii; Acetylcholine; autocrine; mAChR; muscarinic receptor subtypes; neurodegenerative diseases; non-neural cholinergic transmission; unicellular eukaryotes

Mesh:

Substances:

Year:  2017        PMID: 29058403     DOI: 10.1021/acschemneuro.7b00254

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  6 in total

1.  Torn from the headlines: role of public awareness and bench- to-bedside research in prevention and treatment of Acanthamoeba keratitis.

Authors:  Abdul Mannan Baig
Journal:  Eye (Lond)       Date:  2018-12-14       Impact factor: 3.775

2.  Microphthalmia-associated transcription factor up-regulates acetylcholinesterase expression during melanogenesis of murine melanoma cells.

Authors:  Qiyun Wu; Aster H Y Fung; Miranda L Xu; Kaman Poon; Etta Y L Liu; Xiang P Kong; Ping Yao; Qing P Xiong; Tina T X Dong; Karl W K Tsim
Journal:  J Biol Chem       Date:  2018-08-03       Impact factor: 5.157

3.  Polysaccharides from the Edible Mushroom Agaricus bitorquis (Quél.) Sacc. Chaidam Show Anti-hypoxia Activities in Pulmonary Artery Smooth Muscle Cells.

Authors:  Yingchun Jiao; Hui Kuang; Jianan Wu; Qihe Chen
Journal:  Int J Mol Sci       Date:  2019-02-01       Impact factor: 5.923

Review 4.  Fluorescent Biosensors for Neurotransmission and Neuromodulation: Engineering and Applications.

Authors:  Anna V Leopold; Daria M Shcherbakova; Vladislav V Verkhusha
Journal:  Front Cell Neurosci       Date:  2019-10-23       Impact factor: 5.505

Review 5.  Non-Neuronal Transmitter Systems in Bacteria, Non-Nervous Eukaryotes, and Invertebrate Embryos.

Authors:  Yuri B Shmukler; Denis A Nikishin
Journal:  Biomolecules       Date:  2022-02-08

6.  Screening Biophysical Sensors and Neurite Outgrowth Actuators in Human Induced-Pluripotent-Stem-Cell-Derived Neurons.

Authors:  Vaibhav P Pai; Ben G Cooper; Michael Levin
Journal:  Cells       Date:  2022-08-09       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.